Cargando…
Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy
Approximately 820 women die in pregnancy and childbirth every day worldwide, with 99% of these occurring in low-resource settings. The most common causes of maternal mortality are haemorrhage, sepsis and hypertensive disorders. There are established, effective solutions to these complications, howev...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020004/ https://www.ncbi.nlm.nih.gov/pubmed/29945641 http://dx.doi.org/10.1186/s12978-018-0533-4 |
_version_ | 1783335222255812608 |
---|---|
author | Vousden, Nicola Nathan, Hannah L. Shennan, Andrew H. |
author_facet | Vousden, Nicola Nathan, Hannah L. Shennan, Andrew H. |
author_sort | Vousden, Nicola |
collection | PubMed |
description | Approximately 820 women die in pregnancy and childbirth every day worldwide, with 99% of these occurring in low-resource settings. The most common causes of maternal mortality are haemorrhage, sepsis and hypertensive disorders. There are established, effective solutions to these complications, however challenges remain in identifying who is at greatest risk and ensuring that interventions are delivered early when they have the greatest potential to benefit. Measuring vital signs is the first step in identifying women at risk. Overstretched or poorly trained staff and inadequate access to accurate, reliable equipment to measure vital signs can potentially result in delayed treatment initiation. Early warning systems may help alert users to identify patients at risk, especially where novel technologies can improve usability by automating calculations and alerting users to abnormalities. This may be of greatest benefit in under-resourced settings where task-sharing is common and early identification of complications can allow for prioritisation of life-saving interventions. This paper highlights the challenges of accurate vital sign measurement in pregnancy and identifies innovations which may improve detection of pregnancy complications. |
format | Online Article Text |
id | pubmed-6020004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60200042018-07-06 Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy Vousden, Nicola Nathan, Hannah L. Shennan, Andrew H. Reprod Health Commentary Approximately 820 women die in pregnancy and childbirth every day worldwide, with 99% of these occurring in low-resource settings. The most common causes of maternal mortality are haemorrhage, sepsis and hypertensive disorders. There are established, effective solutions to these complications, however challenges remain in identifying who is at greatest risk and ensuring that interventions are delivered early when they have the greatest potential to benefit. Measuring vital signs is the first step in identifying women at risk. Overstretched or poorly trained staff and inadequate access to accurate, reliable equipment to measure vital signs can potentially result in delayed treatment initiation. Early warning systems may help alert users to identify patients at risk, especially where novel technologies can improve usability by automating calculations and alerting users to abnormalities. This may be of greatest benefit in under-resourced settings where task-sharing is common and early identification of complications can allow for prioritisation of life-saving interventions. This paper highlights the challenges of accurate vital sign measurement in pregnancy and identifies innovations which may improve detection of pregnancy complications. BioMed Central 2018-06-22 /pmc/articles/PMC6020004/ /pubmed/29945641 http://dx.doi.org/10.1186/s12978-018-0533-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Vousden, Nicola Nathan, Hannah L. Shennan, Andrew H. Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy |
title | Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy |
title_full | Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy |
title_fullStr | Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy |
title_full_unstemmed | Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy |
title_short | Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy |
title_sort | innovations in vital signs measurement for the detection of hypertension and shock in pregnancy |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020004/ https://www.ncbi.nlm.nih.gov/pubmed/29945641 http://dx.doi.org/10.1186/s12978-018-0533-4 |
work_keys_str_mv | AT vousdennicola innovationsinvitalsignsmeasurementforthedetectionofhypertensionandshockinpregnancy AT nathanhannahl innovationsinvitalsignsmeasurementforthedetectionofhypertensionandshockinpregnancy AT shennanandrewh innovationsinvitalsignsmeasurementforthedetectionofhypertensionandshockinpregnancy |